SPRY ARS Pharmaceuticals, Inc.
$9.00
▼ 3.02%
25
Value
18
P/E-5.18
8
P/B7.76
43
P/S10.60
21
EV/EBITDA-5.54
5
Growth
5
Revenue Growth-5.5%
14
EPS Growth-2209.1%
0
FCF Growth-1418.5%
0
Momentum
46
12-Month Return-35.8%
20
3-Month Return-6.9%
49
1-Month Return9.9%
71
RSI (14)62.89
74
50/200 MABearish
30
Profitability
16
ROE-100.3%
32
ROA-52.3%
0
Gross Margin75.8%
63
Operating Margin-212.9%
0
Net Margin-203.3%
0
FCF Yield-19.2%
0
Risk
34
Beta0.80
75
60-Day Volatility52.2%
0
QScore Analysis